GEP20197038B - Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions
- Google Patents
Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions
Info
Publication number
GEP20197038B
GEP20197038BGEAP201514625AGEAP2015014625AGEP20197038BGE P20197038 BGEP20197038 BGE P20197038BGE AP201514625 AGEAP201514625 AGE AP201514625AGE AP2015014625 AGEAP2015014625 AGE AP2015014625AGE P20197038 BGEP20197038 BGE P20197038B
Authority
GE
Georgia
Prior art keywords
protease inhibitor
prevention
combination
treatment
active principle
Prior art date
Application number
GEAP201514625A
Inventor
Laboratories B.V. Eurodrug
Original Assignee
Eurodrug Laboratories B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurodrug Laboratories B VfiledCriticalEurodrug Laboratories B V
Priority to GEAP201514625ApriorityCriticalpatent/GEP20197038B/en
Publication of GEP20197038BpublicationCriticalpatent/GEP20197038B/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Combination includes protease inhibitor received from the potato and dexpanthenolum.
GEAP201514625A2015-04-172015-04-17Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions
GEP20197038B
(en)
The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treatment of digital ulcers (du) concomitant to systemic sclerosis (ssc)